報價延遲最少15分鐘:2025/01/21 08:41 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
23.07 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.13/2.13
|
|
企業價值
24.08B
|
| 資產負債 |
|
每股賬面淨值
23.86
|
| 現金流量 |
|
現金流量率
0.17
|
| 損益表 |
|
收益
10.58B
|
|
每股收益
35.11
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:41 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. |